Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Takeda
Perspective Therapeutics
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Nurix Therapeutics, Inc.
Incyte Corporation
Incyte Corporation
NuCana plc
University of Pittsburgh
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Medicenna Therapeutics, Inc.
Azienda USL Reggio Emilia - IRCCS
Cancer Research UK
Mayo Clinic
Alliance for Clinical Trials in Oncology
Aminex Therapeutics, Inc.
Symphogen A/S
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Centre Hospitalier Universitaire Vaudois
Massachusetts General Hospital
Massachusetts General Hospital
Rain Oncology Inc
Western Sydney Local Health District
Institut Bergonié
Quadriga Biosciences, Inc.
Xencor, Inc.
Ascentage Pharma Group Inc.
Incyte Corporation
Stony Brook University
AbbVie
AbbVie
Incyte Corporation
Incyte Corporation
Incyte Corporation
Abramson Cancer Center at Penn Medicine
Shenzhen BinDeBio Ltd.
National Cancer Institute (NCI)
INSYS Therapeutics Inc
University of Chicago
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Mannkind Corporation
Wuhan University